SATURN V CAPITAL MANAGEMENT LLC 13F Portfolio
SATURN V CAPITAL MANAGEMENT LLC runs SATURN V CAPITAL MANAGEMENT LLC and currently holds 23 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $697.47M. Their top holdings are AMLX, ALMS, ABVX, PCVX, PHVS. The top five represent 47.2% of reported portfolio weight. SATURN V CAPITAL MANAGEMENT LLC ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, SATURN V CAPITAL MANAGEMENT LLC initiated 2 new positions. They added to 6 existing positions. They trimmed 3 positions. Their current best-performing preview position is AMLX with returns of +29.21%.
Portfolio Value
$697.47M
Alpha Score
241.7
#0 of 1000
Holdings
23
SATURN V CAPITAL MANAGEMENT LLC Current 13F Holdings
Reported holdings from SATURN V CAPITAL MANAGEMENT LLC's latest SEC 13F filing, ranked by portfolio weight.
23 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 AMLX AMYLYX PHARMACEUTICALS INC | 11.91% | $7.69 | $28.14 | +265.93% | Added +6.30% |
 ALMS ALUMIS INC | 11.76% | $10.01 | $7.16 | -28.47% | Trimmed -8.95% |
 ABVX ABIVAX SA | 9.91% | $29.16 | $88.15 | +202.30% | Trimmed -4.39% |
 PCVX VAXCYTE INC | 7.11% | $44.02 | $71.38 | +62.15% | Added +3.44% |
 PHVS PHARVARIS N V | 6.52% | $26.47 | $31.10 | +17.49% | Added +9.38% |
 JAZZ JAZZ PHARMACEUTICALS PLC | 5.56% | $114.12 | $218.42 | +91.40% | Trimmed -1.24% |
 CELC CELCUITY INC | 5.55% | $36.85 | $67.94 | +84.37% | Added +31.36% |
 IRON DISC MEDICINE INC | 5.50% | $53.62 | $62.06 | +15.74% | Added +16.63% |
 DYN DYNE THERAPEUTICS INC | 3.37% | $11.91 | $16.64 | +39.71% | Added +9.40% |
 TRVI TREVI THERAPEUTICS INC | 2.81% | $18.65 | $13.19 | -29.28% | New Buy |
Showing 1-10 of 23